Beatriz Fernandez-Malvar
Vigo, GA, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
SEMA3B is associated with disease activity and infliximab response in IBD patients but does not contribute to the development of intestinal inflammation in vivo.
Journal: Frontiers in immunology
Published: July 31, 2025
Semaphorin4B is elevated in rheumatoid arthritis and enhances the inflammatory phenotype of macrophages and fibroblast-like synoviocytes.
Journal: Arthritis research & therapy
Published: November 26, 2024
Novel endothelial progenitor cells populations as biomarkers of damage and remission in systemic lupus erythematosus.
Journal: Arthritis research & therapy
Published: January 11, 2024
Type I Interferons induce endothelial destabilization in Systemic Lupus Erythematosus in a Tie2-dependent manner.
Journal: Frontiers in immunology
Published: August 14, 2023
Semaphorin3B promotes an anti-inflammatory and pro-resolving phenotype in macrophages from rheumatoid arthritis patients in a MerTK-dependent manner.
Journal: Frontiers in immunology
Published: July 27, 2023
HOXA5 is a key regulator of class 3 semaphorins expression in the synovium of rheumatoid arthritis patients.
Journal: Rheumatology (Oxford, England)
Published: May 30, 2022
Central Role of Semaphorin 3B in a Serum-Induced Arthritis Model and Reduced Levels in Patients With Rheumatoid Arthritis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: October 19, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026